Unit-dose packaging of iron supplements and reduction of iron poisoning in young children

Milton Tenenbein1

  • 1Department of Pediatrics, University of Manitoba Children's Hospital, Winnipeg. mtenenbein@hsc.mb.ca

Insights

Unit-dose packaging for iron supplements significantly reduced iron poisoning calls and deaths in young children. This regulation effectively prevents accidental iron ingestion and fatalities in children under six.

Area of Science:

  • Pediatric Toxicology
  • Public Health Policy
  • Drug Safety Packaging

Background:

  • Iron poisoning is a leading cause of fatal unintentional poisonings in young children.
  • A US Food and Drug Administration (FDA) regulation mandated unit-dose packaging for iron supplements in 1997.

Purpose of the Study:

  • To evaluate the impact of the unit-dose packaging regulation on iron ingestion incidents.
  • To assess the effect of this regulation on iron poisoning-related deaths in children under six years old.

Main Methods:

  • A pre-intervention and post-intervention study design was employed.
  • Data on iron ingestion and poisoning deaths in children under six were collected for 10 years pre-regulation and 5 years post-regulation.
  • Information was sourced from the American Association of Poison Control Centers annual reports.

Main Results:

  • Calls regarding iron ingestion in children under six decreased from 2.99 to 1.91 per 1000 calls (OR, 1.29; P<.001).
  • Deaths due to iron poisoning in this age group dropped significantly from 29 to 1 (OR, 13.56; P = .03).

Conclusions:

  • The unit-dose packaging regulation for iron supplements demonstrably decreased non-intentional ingestion and mortality in young children.
  • This intervention is validated as an effective strategy for preventing iron poisoning and related deaths.
  • Unit-dose packaging should be considered for other high-risk medications to prevent overdose morbidity and mortality.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...